Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
February 6, 2018
Eiger BioPharmaceuticals to Participate in Two Upcoming Investor Conferences in February
PALO ALTO, Calif., Feb. 6, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced ...
February 6, 2018
CymaBay Therapeutics to Participate in Investor Conferences in February
NEWARK, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
February 6, 2018
Mustang Bio to Participate in Immuno-Oncology Panel at BIO CEO & Investor Conference
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
February 6, 2018
Checkpoint Therapeutics to Present at BIO CEO & Investor Conference
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a Fortress Biotech (FBIO) company, today announced that James F. Oliviero, President ...
February 6, 2018
AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference
Lausanne, Switzerland, - February 6, 2018 -   AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
February 5, 2018
Addex Provides Key Financial Indicators and Trading Update
Geneva, Switzerland, 5 February 2018 - Addex Therapeutics (ADXN.SW), a leading company pioneering allosteric modulation-based drug discovery and development, announced today key financial indicators and ...
February 5, 2018
BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Feb. 5, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for ...
February 5, 2018
Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections
BOSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) announced today that on February 2, 2018, it completed the submission of two New ...
February 5, 2018
Palatin Technologies, Inc. Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist
CRANBURY, N.J., Feb. 5, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
February 5, 2018
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting
ROCKVILLE, Md., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment ...
February 5, 2018
Acer Therapeutics Expands Management Team with the Appointment of Three Executives and One New Key Hire
NEWTON, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
February 5, 2018
Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous ...
February 5, 2018
Vermillion Announces the Grant of Two Ovarian Cancer Diagnostic Patents
AUSTIN, Texas, Feb. 5, 2018 /PRNewswire/ -- Vermillion, Inc. (VRML) announced today that it has been granted two new US patents that significantly expand coverage for ...
February 5, 2018
PolarityTE™ Provides Business Updates on Clinical Use of SkinTE™: Regeneration of Full-Thickness Skin
SALT LAKE CITY, Feb. 05, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), today announced that initial results from the clinical applications of the commercially launched ...
February 1, 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
VANCOUVER , Feb. 1, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
February 1, 2018
New Study Demonstrates Improved Hemodynamic Stability After Heart Transplant Surgery using Intraoperative CytoSorb® Blood Purification
MONMOUTH JUNCTION, N.J., Feb. 1, 2018 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation ...
January 31, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
SAN DIEGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd., or Arcturus (ARCT), an RNA medicines company, today announced that it will hold an ...
January 31, 2018
Kiadis Pharma - Last Patient Dosed with ATIR101™ in the Phase II ‘008’ Clinical Trial
AMSTERDAM-DUIVENDRECHT, Netherlands--(BUSINESS WIRE)--Regulatory News: Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell therapy products ...
January 31, 2018
INNATE PHARMA : Prof. Jean-Yves Blay appointed to the Innate Pharma Supervisory Board
Marseille, France, January 31, 2018, 7:00 AM CET Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that Prof. Jean-Yves Blay has ...
January 31, 2018
Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference
BOSTON, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), announced today that its President, Chief Operating Officer and Chief Medical Officer, Evan Loh, ...
Page 99 of 149